| |
|
|
Alzheimer's disease causes the gradual loss of brain cells, resulting in memory loss, disorientation and ultimately death. The areas of the brain that control memory and thinking skills are affected first, but as the disease progresses, cells die in other regions of the brain. Eventually, a person with Alzheimer’s will need complete care.
Although some existing drug treatments can improve or stabilize symptoms and a great deal of research on new treatments is underway, there is currently no cure for Alzheimer’s.
Top of page >>
|
|
|
Cell Search for Key to Dementia
Monday, January 16, 2012
By: Alzheimer's Society, London
A research project designed to help develop new treatments to replace brain cells lost during dementia is being launched at Nottingham University.
|
Study to Look at Nerve Cells in Patients with Alzheimer's Disease
Monday, November 21, 2011
By: University of Bristol, Bristol, U.K.
Researchers at the University of Bristol have been awarded a grant that by using state-of-the-art stem cell technology will enable them to analysis nerve cells produced from skin biopsies of patients with Alzheimer's disease (AD).
|
|
Scientists at New York Stem Cell Foundation, Columbia U. Make Advance in Development of Patient-Specific Stem Cells
Wednesday, October 5, 2011
By: New York Stem Cell Foundation
Major Step Toward Cell-Based Therapies for Life-Threatening Diseases
|
Brain Cells from Your Arm? Research Team Can Do That
Wednesday, September 28, 2011
By: Henry Willson, Columbia (University) Spectator
Medical school professor Asa Abeliovich, the study's senior author, said that neurons produced with his group's technique could be used in the laboratory to study and test new treatments for degenerative brain diseases.
|
|
|
Top of page >>
Before a drug or therapy is made available to the general public, it must be tested for safety and effectiveness. These tests, which are overseen by the National Institutes of Health, rely on volunteer patients and can involve both risks and benefits. Please consult your health-care provider if you are considering whether to participate. For more information, please visit ClinicalTrials.gov.
These clinical trials don't necessarily involve stem cells, but may be worth learning more about:
Missouri clinical trials recruiting Alzheimer's patients >>
All clinical trials recruiting Alzheimer's patients >>
Top of page >>
|
|
Robert Alan Frauenglas
My mother's six-year struggle with Alzheimer's ended in September 2008. Although she was given the latest drugs, they never helped her regain anything she had lost.
Read More >>
|
|
|
Alzheimer’s disease affects as many as 4.5 million Americans, including 1 in every 10 people over age 65. Those numbers will grow as baby boomers age. Studies estimate that the number of Alzheimer’s cases could range from 11 to 16 million nationwide by 2050 unless new treatment options are developed.
The long-term care that is often necessary for Alzheimer’s patients places a tremendous burden on our state and national health systems, as well as on patients’ families. In the U.S., Alzheimer’s-related health care costs are estimated to exceed $100 billion annually, with each individual's care costing an average of $40,000 per year.
It's estimated that more than 88,000 Missourians suffer from Alzheimer’s. Based on current demographic trends, the number could exceed 207,000 by 2025, a 135 percent increase. Direct health care costs and indirect social costs (lost work time, etc.) associated with Alzheimer’s could cost Missourians more than $44 billion over the next 20 years.
|
Top of page >>
| If you find this information helpful, please consider taking action below so we at Missouri Cures may continue our education efforts. Thank you! |
| |
|
|
American Health Assistance Foundation
Alzheimer's Association
Alzheimer's Foundation of America
National Institute on Aging
U.S. National Library of Medicine/National Institutes of Health
Washington University School of Medicine in St. Louis
Top of page >>
|
|
|
Events
Learn more about the promise of stem cell research -- join us at one of these upcoming events!
2012 Missouri Cures Education Foundation Speakers Series
sponsored by
the Staenberg Family Foundation
in conjunction with THF Realty
& MedStem
Feb. 26, Columbia
Mark Kirk, Ph.D.
March 11, Kansas City
Dawn Cornelison, Ph.D.
April 15, Columbia
John Viator, Ph.D.
April 22, St. Louis
Marie Csete, M.D., Ph.D.
May Fund-raiser, St. Louis
Details TBA
June 10, St. Louis
Bill Miller, M.D.
August (date TBA), Springfield
John Viator, Ph.D.
Aug. 26, Kirksville
Dawn Cornelison, Ph.D.
Sept. 9, Columbia
Russell Swerdlow, M.D.
September, Kansas City
Details TBA
October Fund-raiser, St. Louis
Details TBA
Learn more »
|
|
|
